The Flec-SL trial, one of the four major controlled trials in the AFNET, test whether a targeted short-term antiarrhythmic drug therapy after cardioversion is non-inferior to standard long-term therapy.
| Kirchhof, Paulus | Department for Cardiovascular Medicine |
| Kirchhof, Paulus | Department for Cardiovascular Medicine |